GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses
GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses
About this item
Full title
Author / Creator
Sellner, L , Brüggemann, M , Schlitt, M , Knecht, H , Herrmann, D , Reigl, T , Krejci, A , Bystry, V , Darzentas, N , Rieger, M , Dietrich, S , Luft, T , Ho, A D , Kneba, M and Dreger, P
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Allogeneic stem cell transplantation (alloSCT) is used for treating patients with T-prolymphocytic leukemia (T-PLL). However, direct evidence of GvL activity in T-PLL is lacking. We correlated minimal residual disease (MRD) kinetics with immune interventions and T-cell receptor (TCR) repertoire diversity alterations in patients after alloSCT for T-...
Alternative Titles
Full title
GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1891875714
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1891875714
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/bmt.2016.305
